Literature DB >> 18634773

ATP, calcium and magnesium levels in platelets of patients with primary fibromyalgia.

Laura Bazzichi1, Gino Giannaccini, Laura Betti, Laura Fabbrini, Lara Schmid, Lionella Palego, Camillo Giacomelli, Alessandra Rossi, Laura Giusti, Francesca De Feo, Tiziana Giuliano, Giovanni Mascia, Stefano Bombardieri, Antonio Lucacchini.   

Abstract

OBJECTIVES: To evaluate the intracellular levels of the high energy adenosine triphosphate nucleotide ATP and essential divalent cations, calcium and magnesium, in platelets of patients affected by primary fibromyalgia syndrome (FMs). DESIGN AND
METHOD: Platelet ATP and cation concentrations were measured in 25 patients affected by FMs and 25 healthy volunteers through a chemiluminescent and a fluorimetric assay, respectively.
RESULTS: Significant lower ATP levels were observed inside platelets of FM patients (fmol ATP/plt: 0.0169+/-0.0012 vs. healthy controls, fmol ATP/plt: 0.0306+/-0.0023, mean+/-SEM) (*** P<0.0001). A trend towards higher calcium concentrations (P=0.06) together with significant increased magnesium levels were also reported in platelets of patients by comparison with controls (P=0.02).
CONCLUSIONS: This preliminary study suggests that disturbances in the homeostasis of platelet ATP metabolism-signaling and calcium-magnesium flows might have a relevance in the pathogenesis of FMs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18634773     DOI: 10.1016/j.clinbiochem.2008.06.012

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  8 in total

Review 1.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

3.  AMPK Phosphorylation Modulates Pain by Activation of NLRP3 Inflammasome.

Authors:  Pedro Bullón; Elísabet Alcocer-Gómez; Angel M Carrión; Fabiola Marín-Aguilar; Juan Garrido-Maraver; Lourdes Román-Malo; Jesus Ruiz-Cabello; Ognjen Culic; Bernhard Ryffel; Lionel Apetoh; François Ghiringhelli; Maurizio Battino; José Antonio Sánchez-Alcazar; Mario D Cordero
Journal:  Antioxid Redox Signal       Date:  2015-09-16       Impact factor: 8.401

4.  Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia?

Authors:  L Bazzichi; A Rossi; C Zirafa; F Monzani; S Tognini; A Dardano; F Santini; M Tonacchera; M De Servi; C Giacomelli; F De Feo; M Doveri; G Massimetti; S Bombardieri
Journal:  Rheumatol Int       Date:  2010-11-18       Impact factor: 2.631

5.  Pathophysiology of NASH: perspectives for a targeted treatment.

Authors:  Fabio Marra; Sophie Lotersztajn
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Platelet glycolytic metabolism correlates with hemodynamic severity in pulmonary arterial hypertension.

Authors:  Ruth E McDowell; Kulwant S Aulak; Allaa Almoushref; Celia A Melillo; Brittany E Brauer; Jennie E Newman; Adriano R Tonelli; Raed A Dweik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-02-05       Impact factor: 6.011

Review 7.  Vitamin and mineral status in chronic fatigue syndrome and fibromyalgia syndrome: A systematic review and meta-analysis.

Authors:  Monica L Joustra; Isidor Minovic; Karin A M Janssens; Stephan J L Bakker; Judith G M Rosmalen
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

8.  Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the disease.

Authors:  Mario D Cordero; Manuel De Miguel; Ana M Moreno Fernández; Inés M Carmona López; Juan Garrido Maraver; David Cotán; Lourdes Gómez Izquierdo; Pablo Bonal; Francisco Campa; Pedro Bullon; Plácido Navas; José A Sánchez Alcázar
Journal:  Arthritis Res Ther       Date:  2010-01-28       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.